WP7 Subgroup 2 is pleased to announce the publication of its final deliverable - the Core protocol Pilot for Additional Evidence Generation (AEG). This pilot consists of two parts: - Defining core elements of a study protocol for AEG and developing
Publication of a JA2 methodological guideline – Internal validity of non-randomised studies (NRS) on interventions
During Joint Action 1 a methodological guideline on internal validity of randomised studies (RCT) had been elaborated. It was recommended from different sides that EUnetHTA should also produce and consent a guidance document for the assessment of non-randomised studies.
Internal validity of non-randomised studies (NRS) on interventions_Guideline_Final Jul 2015
The methodological guideline on “Methods for health economic evaluations” was developed by WP7, Subgroup 3. The work with the present guideline was initiated to set a general framework for EUnetHTA on how to conduct economic evaluations as well as to increase
The EUnetHTA Submission Template is a flexible tool that reflects all national evidence requirements for reimbursement in Europe. The inclusion of all national requirements means that the template can be broadly applied to national and/or joint assessment. The adaptation process
This document is the final methodological guideline on “Meta-analysis of diagnostic test accuracy studies” produced by WP7's Subgroup 3. Find this methodological guideline's call for public consultation and its results below. Meta-analysis of Diagnostic Test Accuracy Studies_Guideline_Final Nov 2014
This document is WP7's concept paper on osteoarthritis titled the "EunetHTA guideline on data requirements for the assessment of health technologies used for the treatment of osteoarthritis of the hip and knee". EUnetHTA disease-specific guidelines aim to give recommendations about type of